Maize Industry-grade Breeding Array 10K,specification,price,image-Bio-Equip in China

Product Detail
Company Profile

Maize Industry-grade Breeding Array 10K

China's First Maize Breeding Microarray with Full Intellectual Property Rights

(On SNP Markers, microarrays, reagent kits and microarray scanners.)

As China's First Maize Breeding Microarray, Maize Industry-grade Breeding Array 10K is designed with probe sequences derived from nearly 500 maize inbred line resequencing datasets, covering core germplasm resources from both domestic and international sources, ensuring broad applicability. Probes are based on the fourth edition of the B73 reference genome (B73 RefGen_v4), allowing easy conversion to other single-marker assays or integration with other marker results.

This microarray features nearly 10,000 markers, optimized using tests from about 200 inbred and hybrid lines, and is evenly distributed across the maize genome. It boasts an average call rate of 99.3% and a reproducibility rate of 99.9%, significantly accelerating the development of high-quality maize varieties and enhancing the sustainability and economic benefits of agricultural production.

Applications

DNA Fingerprinting
Genetic Background Analysis
Varietal Differences Comparison
SSR Locus Variation Comparison
Functional Gene Detection for Blooming Resistance and Other Traits
Authentication and Evaluation of DH Lines
Genomic Selection

Features

Extendable: The technology allows researchers to add new custom content to existing panels, enabling researchers to keep up to date with recent discoveries.
Cost-effective: Offers cost advantages at equivalent SNP density levels, catering to the demands of large-scale industrial applications.
Efficient: One experimenter can process up to 2304 samples in a single round.Obtain genotype data directly within 72h turnaround per experiment.
Accurate: Each marker is assayed 15-30 times. Average call rate is as high as 99.32%, and the reproducibility is up to 99.85%.

About LASO Biotech

Suzhou LASO Biotech is the first company in China for the proprietary development, production, and commercialization of microarray technology platform, providing an integrated solution including chips (customizable), the OmniScan device, reagents, softwares and algorithms.

As of now, Laso Biotech has obtained 13 invention patents, 5 utility model patents, 3 design patents, and 1 medical device registration certificate, making it the company with the most comprehensive intellectual property portfolio and independently controllable core technologies for microarray under Chinese law.